GlassScriptPhysician profile
William L Mecca
NPI 1730167487
$2,739.09
in general payments reported to CMS, 2019-2025
13 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $197 · 2021: $339 · 2022: $488 · 2023: $687 · 2024: $397 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,764.27 | 2021-2025 | Resolute Onyx, Symplicity G3, Euphora |
| Boston Scientific Corporation | $385.16 | 2019-2020 | |
| Medtronic Vascular, INC. | $172.99 | 2019-2020 | |
| Abiomed | $134.13 | 2019-2023 | Impella |
| Inari Medical, INC. | $125.55 | 2021-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Ekos Corporation | $32.01 | 2019 | |
| Cordis US Corp. | $27.27 | 2022 | |
| Cardinal Health 200 LLC | $26.70 | 2020 | |
| Philips North America LLC | $23.15 | 2019 | |
| Amgen INC. | $14.53 | 2020 | |
| Amarin Pharma, INC. | $13.40 | 2020 | |
| W. L. Gore & Associates, INC. | $11.32 | 2020 | |
| Vasorum USA INC. | $8.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Mecca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.